What is Glofitamab: Uses, Dosage, Side Effects and More

Glofitamab is a targeted cancer immunotherapy medication that helps your immune system fight certain types of blood cancers. This medicine works by connecting cancer cells to your body's natural defense cells, making it easier for your immune system to recognize and destroy the cancer.

If you or someone you care about has been prescribed glofitamab, you probably have many questions about how it works and what to expect. Let's walk through everything you need to know about this treatment in a way that feels clear and manageable.

What is Glofitamab?

Glofitamab is a type of cancer medicine called a bispecific antibody. Think of it as a special protein that acts like a bridge between two important things in your body - the cancer cells you want to eliminate and the immune cells that can destroy them.

This medication is specifically designed to treat certain types of non-Hodgkin lymphoma, which is a cancer that affects your lymphatic system. The lymphatic system is part of your body's infection-fighting network, and when it develops cancer, it needs targeted help to get back on track.

Glofitamab comes as a liquid that gets delivered directly into your bloodstream through an IV infusion. This allows the medicine to travel throughout your body and reach cancer cells wherever they might be hiding.

What is Glofitamab Used For?

Glofitamab treats adults with diffuse large B-cell lymphoma (DLBCL) that has come back after other treatments or hasn't responded to previous therapies. This includes several related conditions that behave similarly to DLBCL.

Your doctor typically considers this medication when you've already tried at least two other treatment approaches. It's what oncologists call a "third-line" treatment, meaning it becomes an option when the more commonly used treatments haven't worked as hoped.

The medicine specifically targets B-cell lymphomas because these cancers develop from a particular type of immune cell called B-cells. When these cells become cancerous, they lose their ability to fight infections properly and instead multiply uncontrollably.

How Does Glofitamab Work?

Glofitamab works by grabbing onto two different types of cells at the same time - the cancer cells and your healthy immune cells called T-cells. When it connects these cells, it essentially introduces them to each other and signals your T-cells to attack the cancer.

This process is called "redirected T-cell cytotoxicity," which sounds complicated but basically means your own immune system gets redirected to fight the cancer more effectively. It's like having a skilled mediator help your body's natural defenses recognize the enemy.

The medication is considered a moderately strong cancer treatment. While it's powerful enough to shrink tumors and put some people into remission, it typically works more gently than traditional chemotherapy. Many people experience fewer of the harsh side effects that come with conventional cancer drugs.

How Should I Take Glofitamab?

Glofitamab gets administered through an IV infusion in a hospital or cancer treatment center. You won't take this medication at home - it requires careful medical supervision during each treatment session.

Before starting glofitamab, your healthcare team will likely give you other medications to help prevent certain side effects. This might include steroids and other supportive medicines that help your body handle the treatment better.

The infusion process usually takes several hours, and you'll need to stay for monitoring afterward. Your medical team will watch for any immediate reactions and make sure you're feeling stable before you go home. You can eat normally before treatment, though some people find that having a light meal helps them feel more comfortable during the longer infusion sessions.

How Long Should I Take Glofitamab For?

The typical treatment course with glofitamab lasts about 12 cycles, with each cycle being 21 days apart. This means you'll receive treatments roughly every three weeks for about 8 to 9 months total.

Your doctor will monitor how well the treatment is working throughout this period using scans and blood tests. If the cancer responds well, you might complete the full 12 cycles. However, if you experience serious side effects or the cancer doesn't respond, your doctor might adjust the plan.

Some people may need to take breaks between treatments to allow their body to recover, especially if their blood counts drop too low. Your healthcare team will work with you to find the right balance between fighting the cancer effectively and maintaining your overall health and quality of life.

What Are the Side Effects of Glofitamab?

Like all cancer treatments, glofitamab can cause side effects, though not everyone experiences them the same way. Understanding what might happen can help you prepare and know when to reach out for support.

The most common side effects that many people experience include fatigue, fever, nausea, and diarrhea. These typically feel manageable and often improve as your body adjusts to the treatment over the first few cycles.

Here are the more frequent side effects you might notice:

• Tiredness or fatigue that feels more intense than usual
• Fever or chills, especially in the first day or two after treatment
• Nausea or upset stomach
• Diarrhea or changes in bowel movements
• Decreased appetite
• Muscle or joint aches
• Headaches
• Skin rash or itching

These symptoms usually respond well to supportive care and medications that your healthcare team can prescribe.

There are also some more serious side effects that require immediate medical attention, though they're less common. The most important one to watch for is called cytokine release syndrome (CRS), which happens when your immune system becomes overly activated.

Signs of CRS that need urgent medical care include:

• High fever (over 100.4°F) that doesn't respond to fever reducers
• Difficulty breathing or shortness of breath
• Rapid heartbeat or chest pain
• Severe nausea and vomiting
• Confusion or difficulty thinking clearly
• Severe muscle weakness

Your medical team will monitor you closely, especially during your first few treatments, to catch any signs of CRS early. They have effective treatments available if this occurs.

Some rare but serious side effects can also affect your nervous system, blood counts, or liver function. Your healthcare team will do regular blood tests to monitor these areas and adjust your treatment if needed.

Who Should Not Take Glofitamab?

Glofitamab isn't right for everyone, and your doctor will carefully evaluate whether it's a safe choice for your specific situation. People with certain health conditions or circumstances may need to avoid this treatment or consider alternatives.

You should not receive glofitamab if you have a known severe allergic reaction to this medication or any of its ingredients. Your doctor will review your allergy history carefully before starting treatment.

Certain health conditions require extra caution or may make glofitamab unsuitable:

• Active, serious infections that aren't under control
• Severe heart problems or recent heart attack
• Significant liver disease or liver function problems
• Very low blood cell counts that haven't stabilized
• Autoimmune diseases that are actively flaring
• Recent major surgery or procedures

Pregnancy and breastfeeding also require special consideration. Glofitamab can harm a developing baby, so women who might become pregnant need to use effective birth control during treatment and for several months afterward.

Your doctor will also consider your overall health status, other medications you're taking, and how well you've recovered from previous cancer treatments before recommending glofitamab.

Glofitamab Brand Names

The brand name for glofitamab is Columvi. This is the name you'll see on your medical records and insurance paperwork when you receive this treatment.

Columvi is manufactured by Genentech, a member of the Roche Group, and it's the only version of glofitamab currently available in the United States. Unlike some medications that have multiple brand names or generic versions, glofitamab is only available under this one brand name.

When talking with your healthcare team, insurance company, or pharmacist, you can refer to your medication as either "glofitamab" or "Columvi" - they'll know you're talking about the same medicine.

Glofitamab Alternatives

If glofitamab isn't the right choice for you, there are other treatment options available for relapsed or refractory B-cell lymphomas. Your oncologist can help you understand which alternatives might work best for your specific situation.

Other bispecific antibodies that work similarly to glofitamab include mosunetuzumab and epcoritamab. These medications use the same basic approach of connecting cancer cells to immune cells, though they have slightly different side effect profiles and dosing schedules.

CAR-T cell therapy represents another innovative approach where your own immune cells get modified in a laboratory to better fight cancer, then returned to your body. This treatment can be very effective but requires a more complex process and longer recovery time.

Traditional treatment options that your doctor might also consider include:

• Different combinations of chemotherapy drugs
• Targeted therapies that block specific cancer pathways
• Radiation therapy for localized disease
• Clinical trials testing newer experimental treatments
• Stem cell transplant in appropriate candidates

The best choice depends on factors like your overall health, previous treatments you've received, and the specific characteristics of your lymphoma. Your healthcare team will work with you to weigh the benefits and risks of each option.

Is Glofitamab Better Than Rituximab?

Glofitamab and rituximab work in different ways and are typically used at different stages of lymphoma treatment, so comparing them isn't quite straightforward. Rituximab is usually part of first-line treatment combinations, while glofitamab is reserved for later-line therapy.

Rituximab is a monoclonal antibody that targets CD20 on B-cells and has been a cornerstone of lymphoma treatment for many years. It's often combined with chemotherapy and has a well-established safety profile that most people tolerate quite well.

Glofitamab, as a bispecific antibody, can potentially be more effective in certain situations because it actively recruits your immune system to fight cancer. For people whose lymphoma has stopped responding to rituximab-based treatments, glofitamab offers a different mechanism of action that might work better.

The choice between these medications typically depends on where you are in your treatment journey rather than which one is "better" overall. Your oncologist will consider your treatment history, current health status, and the specific characteristics of your lymphoma when making recommendations.